425: Strive & Semler Scientific Announce Merger Filing

Strive, Inc. and Semler Scientific, Inc. have filed a Form 425 communication regarding their proposed business combination, emphasizing cautionary forward-looking statements.

Summary

• Strive, Inc. and Semler Scientific, Inc. are pursuing a proposed business combination.
• The communication was reposted on X.com by Logan Beirne, Chief Legal Officer of Strive, Inc., on October 24, 2025.
• This filing serves as a cautionary statement regarding forward-looking statements related to the proposed transaction.
• Strive intends to file a Registration Statement on Form S-4 with the SEC to register the Class A common stock to be issued in connection with the proposed transaction.
• The Registration Statement will include an Information Statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific to seek their approval of the proposed transaction.

Sentiment

Score: 6

Explanation: The filing announces a significant corporate action (merger) which is generally positive for growth, but it is heavily weighted with cautionary statements and risks, leading to a neutral-to-slightly-positive sentiment. The procedural nature of the filing also limits strong positive sentiment.

Positives

• Anticipated strategic benefits of the proposed transaction.
• Anticipated financial benefits of the proposed transaction.
• Expected positive impact of the proposed transaction on the combined company's future financial performance.
• Anticipated cost savings and strategic gains from the proposed transaction.

Negatives

• Integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.

Risks

• The occurrence of any event, change, or circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including anticipated cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact anticipated benefits.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors, including unknown or unpredictable factors, could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

The outlook and expectations of Strive and Semler Scientific regarding the proposed transaction, including strategic and financial benefits, the expected impact on the combined company's future financial performance, and the timing of the closing, are subject to inherent risks and uncertainties. The ability to successfully integrate the combined businesses is also a key forward-looking aspect.

Management Comments

• Logan Beirne, Chief Legal Officer of Strive, Inc., reposted the communication on X.com on October 24, 2025.
• Strive and Semler Scientific believe that their expectations with respect to forward-looking statements are based upon reasonable assumptions within the bounds of their existing knowledge of their business and operations.

Industry Context

This filing pertains to a specific business combination between Strive, Inc. and Semler Scientific, Inc. It highlights the procedural steps and risks associated with mergers, including integration challenges and the potential impact of broader economic conditions. The mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' suggests a potential strategic shift or focus for the combined entity that aligns with emerging trends in corporate treasury management and digital asset adoption.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is a risk factor.

Stakeholder Impact

• Shareholders of Semler Scientific will vote on the proposed transaction and will receive Strive Class A common stock if approved, potentially experiencing dilution.
• Customers and employees of both Strive and Semler Scientific may experience adverse reactions or changes to business/employee relationships due to the transaction.
• Investment professionals and regulatory authorities are impacted by the detailed disclosures and the need to interpret forward-looking statements.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC.
• The Registration Statement will include an Information Statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available.

Key Dates

Recommendation

This filing is a procedural communication regarding a proposed business combination, not a financial performance update. While the merger itself is a significant event, this specific document primarily outlines the process, cautionary statements, and risks. A seasoned investor would likely hold their position pending further detailed financial disclosures in the S-4 and proxy statements, which will provide more concrete information for a definitive investment decision. The document does not provide enough new financial data to warrant a strong buy or sell recommendation at this stage.

Keywords

Strive Inc., Semler Scientific Inc., Merger, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Corporate Governance, Risk Management, Bitcoin Treasury Strategy, Digital Assets